Literature DB >> 17565221

Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study.

Edoardo Vicenzini1, Maria Chiara Ricciardi, Marta Altieri, Francesco Puccinelli, Novella Bonaffini, Vittorio Di Piero, Gian Luigi Lenzi.   

Abstract

BACKGROUND: An impairment of cerebral microvessels is reported both in normal ageing and in senescence-associated processes, as well as in Alzheimer's disease (AD) and vascular dementia (VaD). The aim of this study was to explore cerebral hemodynamics by transcranial Doppler in VaD and AD, compared with age-matched control subjects.
METHODS: Transcranial Doppler was investigated in all patients in the basal condition. Cerebral vasoreactivity to hyper- and hypocapnia was evaluated with CO2 mixture inhalation followed by hyperventilation.
RESULTS: We studied 60 AD and 58 VaD patients and 62 nondemented controls. Both AD and VaD subjects showed lower flow velocities (FV) and higher pulsatility indices (PI) as compared with controls. Lower total vasomotor reactivity and lower response to hypercapnia were observed in the AD and VaD groups as compared with controls. AD and VaD patients did not show significant differences in FV, PI values or cerebral vasoreactivity.
CONCLUSIONS: Reduced FV and increased PI with a significant vasoreactivity reduction in VaD and AD patients are indicators of impairment of cerebral microvasculature circulation in both diseases. The identification of vascular function impairment in all kinds of dementia could be of help in identifying patients who would thus benefit more from specific therapeutic approaches. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17565221     DOI: 10.1159/000103642

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  54 in total

1.  Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease.

Authors:  Salo Haratz; Galit Weinstein; Noa Molshazki; Michal Schnaider Beeri; Ramit Ravona-Springer; Oleg Marzeliak; Uri Goldbourt; David Tanne
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

3.  Hypertension and cerebral vasoreactivity: a continuous arterial spin labeling magnetic resonance imaging study.

Authors:  Ihab Hajjar; Peng Zhao; David Alsop; Vera Novak
Journal:  Hypertension       Date:  2010-09-27       Impact factor: 10.190

4.  The effects of transcranial LED therapy (TCLT) on cerebral blood flow in the elderly women.

Authors:  Afonso S I Salgado; Renato A Zângaro; Rodolfo B Parreira; Ivo I Kerppers
Journal:  Lasers Med Sci       Date:  2014-10-03       Impact factor: 3.161

5.  Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study.

Authors:  Ihab Hajjar; Farzaneh Sorond; Yi-Hsiang Hsu; Andrew Galica; L Adrienne Cupples; Lewis A Lipsitz
Journal:  Stroke       Date:  2010-02-25       Impact factor: 7.914

Review 6.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

7.  Optical imaging in an Alzheimer's mouse model reveals amyloid-β-dependent vascular impairment.

Authors:  Alexander J Lin; Gangjun Liu; Nicholas A Castello; James J Yeh; Rombod Rahimian; Grace Lee; Victoria Tsay; Anthony J Durkin; Bernard Choi; Frank M LaFerla; Zhongping Chen; Kim N Green; Bruce J Tromberg
Journal:  Neurophotonics       Date:  2014-07       Impact factor: 3.593

8.  Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.

Authors:  Jharon N Silva; Oksana Polesskaya; Helen S Wei; Izad-Yar D Rasheed; Jeffrey M Chamberlain; Christopher Nishimura; Changyong Feng; Stephen Dewhurst
Journal:  Microcirculation       Date:  2014-10       Impact factor: 2.628

Review 9.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.

Authors:  Ihab Hajjar; Meaghan Hart; Yu-Ling Chen; Wendy Mack; Vera Novak; Helena C Chui; Lewis Lipsitz
Journal:  J Am Geriatr Soc       Date:  2013-01-25       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.